Geldanamycin and derivatives inhibit cancer invasion and identify novel targets
Details for Australian Patent Application No. 2005228886 (hide)
International Classifications
Event Publications
26 October 2006 PCT application entered the National Phase
PCT publication WO2005/095347 Priority application(s): WO2005/095347
16 November 2006 Amendment Made
The nature of the amendment is as shown in the statement(s) filed 09 Oct 2006
9 April 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2005228888-Processes for the production of xylitol
2005228881-Heterocyclic CGRP antagonists for the treatment of migraine
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser